 |
PDBsum entry 4cdq
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
297 a.a.
|
 |
|
|
|
|
|
|
|
245 a.a.
|
 |
|
|
|
|
|
|
|
242 a.a.
|
 |
|
|
|
|
|
|
|
58 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Virus
|
 |
|
Title:
|
 |
Crystal structure of human enterovirus 71 in complex with the uncoating inhibitor gpp2
|
|
Structure:
|
 |
Vp1. Chain: a. Engineered: yes. Vp2. Chain: b. Engineered: yes. Vp3. Chain: c. Engineered: yes.
|
|
Source:
|
 |
Enterovirus a71. Organism_taxid: 39054. Expressed in: chlorocebus aethiops. Expression_system_taxid: 9534. Expression_system_cell_line: vero cells. Expression_system_cell_line: vero cells
|
|
Resolution:
|
 |
|
2.65Å
|
R-factor:
|
0.245
|
R-free:
|
0.246
|
|
|
Authors:
|
 |
L.Decolibus,X.Wang,J.A.B.Spyrou,J.Kelly,J.Ren,J.Grimes,G.Puerstinger, N.Stonehouse,T.S.Walter,Z.Hu,J.Wang,X.Li,W.Peng,D.Rowlands,E.E.Fry, Z.Rao,D.I.Stuart
|
|
Key ref:
|
 |
L.De Colibus
et al.
(2014).
More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules.
Nat Struct Biol,
21,
282-288.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
05-Nov-13
|
Release date:
|
12-Feb-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
B2ZUN0
(B2ZUN0_HE71) -
Genome polyprotein from Human enterovirus 71
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2193 a.a.
297 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
B2ZUN0
(B2ZUN0_HE71) -
Genome polyprotein from Human enterovirus 71
|
|
|
|
Seq: Struc:
|
 |
 |
 |
2193 a.a.
245 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B, C, D:
E.C.2.7.7.48
- RNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
RNA(n)
|
+
|
ribonucleoside 5'-triphosphate
|
=
|
RNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains A, B, C, D:
E.C.3.4.22.28
- picornain 3C.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Gln-|-Gly bond in the poliovirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains A, B, C, D:
E.C.3.4.22.29
- picornain 2A.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Selective cleavage of Tyr-|-Gly bond in the picornavirus polyprotein. In other picornavirus reactions Glu may be substituted for Gln, and Ser or Thr for Gly.
|
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains A, B, C, D:
E.C.3.6.1.15
- nucleoside-triphosphate phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
|
 |
 |
 |
 |
 |
ribonucleoside 5'-triphosphate
|
+
|
H2O
|
=
|
ribonucleoside 5'-diphosphate
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Nat Struct Biol
21:282-288
(2014)
|
|
PubMed id:
|
|
|
|
|
| |
|
More-powerful virus inhibitors from structure-based analysis of HEV71 capsid-binding molecules.
|
|
L.De Colibus,
X.Wang,
J.A.Spyrou,
J.Kelly,
J.Ren,
J.Grimes,
G.Puerstinger,
N.Stonehouse,
T.S.Walter,
Z.Hu,
J.Wang,
X.Li,
W.Peng,
D.J.Rowlands,
E.E.Fry,
Z.Rao,
D.I.Stuart.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Enterovirus 71 (HEV71) epidemics in children and infants result mainly in mild
symptoms; however, especially in the Asia-Pacific region, infection can be
fatal. At present, no therapies are available. We have used structural analysis
of the complete virus to guide the design of HEV71 inhibitors. Analysis of
complexes with four 3-(4-pyridyl)-2-imidazolidinone derivatives with varying
anti-HEV71 activities pinpointed key structure-activity correlates. We then
identified additional potentially beneficial substitutions, developed methods to
reliably triage compounds by quantum mechanics-enhanced ligand docking and
synthesized two candidates. Structural analysis and in vitro assays confirmed
the predicted binding modes and their ability to block viral infection. One
ligand (with IC50 of 25 pM) is an order of magnitude more potent than the best
previously reported inhibitor and is also more soluble. Our approach may be
useful in the design of effective drugs for enterovirus infections.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
| | |